Sains Malaysiana 43(2)(2014):
233–240
Ko-pengekspresan Reseptor Estrogen beta (ERβ) dan Aktin Otot Licin pada
Tumor Filodes
di Payudara: Suatu Kajian Tisu Mikroarai
(The Co-expression of
Estrogen Receptor beta (ERβ) and Smooth Muscle Actin in Phyllodes Tumour of
Breast: A Tissue Microarray Study)
NURHAYATI
H. MUNAWER1,
SITI-AISHAH MD ALI*1,
REENA MD ZIN1
&
ROHAIZAK MUHAMMAD2
1Jabatan Potologi, Pusat Perubatan Universiti Kebangsaan Malaysia
(PPUKM)
56000 Kuala Lumpur, Malaysia
2Jabatan
Surgeri, Pusat Perubatan Universiti Kebangsaan Malaysia (PPUKM)
56000
Kuala Lumpur, Malaysia
Diserahkan:
6 Disember 2012/Diterima: 18 Mei 2013
ABSTRAK
Proliferasi
tumor filodes tertumpu terutama pada bahagian stroma yang dianggap sebagai
komponen neoplastik bagi tumor filodes. Reseptor Estrogen (ER) yang memainkan peranan dalam payudara
neoplastik juga terlibat dalam perkembangan tumor filodes. ERβ adalah satu jenis klon ER yang dilaporkan hadir
pada stroma tumor payudara manakala pengekspresan aktin otot licin (SMA)
di stroma dapat membandingkan gred histologi tumor filodes. Kami membandingkan pengekspresan ERβ dengan SMA pada komponen stroma
tumor filodes menggunakan teknik tisu mikroarai (TMA). TMA dibentuk
ke atas 77 kes tumor filodes (46 benigna, 17 pinggiran dan 14 malignan)
menggunakan jarum berdiameter 0.6 mm (Alphelys Plaisir, Perancis) dan pewarnaan
imunohistokimia dijalankan menggunakan penanda molekul ERβ dan SMA.
Tumor filodes kerap hadir pada wanita berusia lebih daripada 40 tahun dengan
tumor filodes benigna menunjukkan median umur pesakit paling rendah (p=0.017). Ekspresi ERβ dalam komponen stroma meningkat dengan gred
histologi tumor. Sementara SMA menunjukkan ekspresi
pada 62.8, 41.2 dan 57.1%, masing-masing bagi tumor filodes benigna, pinggiran
dan malignan. Kedua-dua ERβ (p=0.024) dan SMA lebih cenderung hadir
pada wanita ≥40 tahun. Kajian menunjukkan hubungan signifikan antara
ko-pengekspresan ERβ dan SMA (p=0.047) dan 65.5% daripadanya
adalah wanita berumur lebih daripada 40 tahun. Ekspresi SMA yang
tinggi pada stroma tumor filodes benigna mungkin menunjukkan potensi
proliferasi tumor ini untuk menjadi malignan. Ekspresi
tinggi ERβ dengan tumor filodes malignan dan hubungannya dengan SMA mencadangkan
ko-pengekspresan kedua-dua penanda molekul ini mungkin berperanan dalam
tumorigenesis stroma tumor filodes.
Kata kunci: ERβ; SMA;
tisu mikroarai; tumor filodes
ABSTRACT
Proliferation of phyllodes tumour is
mainly in the stromal that is considered as the neoplastic component of
phyllodes tumour. Estrogen Receptor (ER) that plays an important role in breast
neoplasm is also involved in progression of phyllodes tumour. ERβ is a
type of ER which was reported to be expressed in the breast stroma while the
expression of smooth muscle actin (SMA) in the stroma may differentiate
histological grade of phyllodes tumour. We compared the expression of ERβ to SMA in
stromal component of phyllodes tumour using tissue microarray (TMA) technique. A TMA was
constructed on 77 cases of phyllodes tumour (46 benign, 17 boderline and 14
malignant) using 0.6 mm punch kit (Alphelys Plaisir, France) and
immunohistochemical staining was done using ERβ and SMA. Phyllodes tumour
seen in women aged more than 40 year-old with benign phyllodes tumour showed
the lowest median of age (p=0.017). ERβ expression in stromal
component increased with histological grade of the tumour. SMA was positive in 62.8,
41.2 and 57.1%, of benign, borderline and malignant phyllodes tumour,
respectively. Both ERβ (p=0.024) and SMA were commonly
expressed in women aged ≥40 years. We found a significant co-expression of
ERβ and SMA (p=0.047) and 65.5% of these cases occured in women aged
more than 40 years-old. The high expression of SMA in stroma of benign
phyllodes tumour may demonstrate the potential of proliferation of this tumour
to become malignant. High expression of ERβ of malignant phyllodes tumour
and its significant association with SMA suggests that co-expression of these two
markers may play a role in stromal tumorigenesis of phyllodes tumour.
Keywords: ERβ; phyllodes tumour; SMA;
tissue microarray
RUJUKAN
Ang, M.K., Ooi, A.S.,
Thike, A.A., Tan, P., Zhang, Z., Dykema, K., Furge, K., Teh, B.T. & Tan,
P.H. 2011. Molecular classification of breast phyllodes tumors: validation of
the histologic grading scheme and insights into malignant progression. Breast
Cancer Research Treatment 129: 319- 329.
Bubendorf,
L., Nocito, A., Moch, H. & Sauter, G. 2001. Tissue microarray (TMA)
technology: miniaturized pathology archives for high-throughput in situ studies. Journal of Pathology 195: 72-79.
Chen,
C.M., Chen, C.J., Chang, C.L., Shyu, J.S., Hsieh, H.F. & Harn, H.J. 2000. CD34,
CD117, and actin expression in phyllodes tumor of the breast. Journal
of Surgical Research 94: 84-91.
Chong, J.K. & Woo,
H.K. 1993. Patterns of p53 expression in phyllodes tumors of
the breast. Journal of Korean Medical Science 8(5): 325-328.
Chua, C.L., Thomas, A.
& Ng, B.K. 1989. Cystosarcoma phyllodes: A review of surgical options. Surgery 105: 141- 147.
Cîmpean, A.M., Raica, M.
& Narita, D. 2005. Diagnostic significance of the
immunoexpression of CD34 and smooth muscle cell actin in benign and malignant
tumors of the breast. Romanian Journal of Morphology and Embryology 46(2):
123-129.
Clark,
S.E., Warwick, J., Carpenter, R., Bowen, R.L., Duffy, S.W. & Jones, J.L.
2011. Molecular subtyping of DCIS: Heterogeneity of breast cancer reflected in
pre-invasive disease. British Journal of Cancer 104: 120-127.
Feakins, R.M., Mulcahy,
H.E., Nickols, C.D. & Wells, C.A. 1999. p53 expression in phyllodes tumours is associated with histological features of
malignancy but does not predict outcome. Histopathology 35: 162-169.
Feakins, R.M., Wells,
C.A., Young, K.A. & Sheaff, M.T. 2000.
Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas
of the breast. Human Pathology 31(10): 1214-1222.
Esposito,
N.N., Mohan, D., Brufsky, A., Lin, Y., Kapali, M. & Dabbs, D.J. 2006. Phyllodes tumor. A
clinicopathologic and immunohistochemical study of 30 cases. Archives
Pathology & Laboratory Medicine 130: 1516–1521.
Glass,
A.G., Lacey Jr., J.V., Carreon, J.D. & Hoover, R.N. 2007. Breast cancer
incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening
mammography, and estrogen receptor status. Journal of the National Cancer
Institute 99: 1152-1161.
Gustafsson, J.A. 1999. Estrogen receptor
β- a new dimension in estrogen mechanism of action. Journal of
Endocrinology 163: 379-383.
Iau, P.T., Lim, T.C., Png, D.J. & Tan, W.T. 1998. Phyllodes
tumour: An update of 40 cases. ANNALS Academy of Medicine Singapore 27(2):
200-203.
Jacobs,
T.W., Chen, Y.Y., Guinee, D.G.Jr., Holden, J.A., Cha, I., Bauermeister, D.E.,
Hashimoto, B., Wolverton, D. & Hartzog, G. 2005. Fibroepithelial lesions
with cellular stroma on breast core needle biopsy: Are there predictors of
outcome on surgical excision? American Journal of Clinical Pathology 3:
342-354.
Jara-Lazaro, A.R. & Tan, P.H. 2009. Molecular pathogenesis of progression and recurrence in breast
phyllodes tumors. American Journal of Translational Research 1(1):
23-34.
Kilarski,
W.W., Jura, N. & Gerwins, P. 2005. An ex vivo model
for functional studies of myofibroblasts. Laboratory Investigation 85(5):
643-654.
Kuijper, A.,
Buerger, H., Simon, R., Schaeter, K.L., Croonen, A., Boecker, W., van der Wall,
E. & van Diest, P.J. 2002. Analysis of the progression of
fibroepithelial tumours of the breast by PCR-based clonality assay. Journal
of Pathology 197(5): 575-581.
Liporace,
J., Willcox, K. & Thomas, D.A. 2008. Neurologic
considerations in the postmenopausal women. Dlm Clinical
Neurology of the Older Adult. Edisi ke-2, disunting oleh Siven, J.I.
& Malamut, B.L. Philadelphia: Lippincott Williams & Wilkins. hlm. 54-64.
Munirah,
M.A., Siti-Aishah, M.A., Reena, M.Z., Sharifah, N.A., Rohaizak, M., Norlia, A.,
Rafie, M.K.M., Asimiati, A., Hisham, A., Fuad, I., Shahrun, N.S. & Das, S.
2011. Identification of different subtypes of breast cancer
using tissue microarray. Romanian Journal of Morphology and
Embryology 52(2): 669-677.
Nakopoulou, L., Lazaris, A.C., Panayotopoulou, E.G., Giannopoulou,
I., Givalos, N., Markaki, S. & Keramopoulos, A. 2004. The favourable prognostic value of estrogen receptor β
immunohistochemical expression in breast cancer. Journal of Clinical
Pathology 57: 523-528.
Noranizah,
W., Siti-Aishah, M.A., Munirah, M.A., Norazlin, M.H., Rohaizak, M., Naqiyah,
I., Sharifah, N.A. & Das, S. 2010. Immunohistochemical
expression of vascular endothelial growth factor (VEGF) and p53 in breast
lesions. Clinica Terapeutica 161(2): 129-137.
Nurhayati, H.M., Reena, M.Z.,
Siti-Aishah, M.A., Rohaizak, M., Jasmi, A. & Srijit, D. 2012. ER. p53 and MIB-1 are
significantly associated with malignant phyllodes tumor. Biomedical Journal 35(6): 486-492.
Patrone, C., Cassel, T.N., Pettersson, K., Piao, Y.S., Cheng, G.,
Ciana, P., Maggi, A., Warner, M., Gustafsson, J.A. & Nord, M. 2003. Regulation of postnatal lung development and homeostasis by
estrogen receptor beta. Molecular of Cell Biology 23(23):
8542-8552.
Rousseau,
M.E. 2004. Health care of midlife and aging women. Dlm Varney’s Midwifery. Edisi ke-4, disunting oleh
Varney, H., Kriebs, J.M. & Gegor, C.L. Sudbury: Jones and Bartlett
Publishers.
Sapino, A.,
Bosco, M., Cassoni, P., Castellano, I., Arisio, R., Cserni, G., Dei Tos, A.P.,
Fortunati, N., Catalano, M.G. & Bussolati, G. 2006. Estrogen
receptor-β is expressed in stromal cells of fibroadenoma and phyllodes
tumors of the breast. Modern Pathology 19: 599-606.
Scobie,
G.A., Macpherson, S., Millar, M.R., Groome, N.P., Romana, P.G. & Saunders,
P.T.K. 2002. Human oestrogen receptor: Differential expression of Eralpha and
beta and the identification of Erbeta variants. Steroids 67: 985-992.
Shaaban, A., O’Neill, P.A., Davies, M.P.A., Sibson, R., West,
C.R., Paul, H. & Christopher, S. 2003. Declining estrogen receptor-[beta]
expression defines malignant progression of human breast neoplasia. The American
Journal of Surgical Pathology 12(27): 1502-1512.
Shantakumar, S., Terry, M.B., Teitelbaum, S.L.,
Britton, J.A., Millikan, R.C., Moorman, P.G., Neugut, A.I. & Gammon, M.D.
2007. Reproductive factors and breast cancer risk
among older women. Breast Cancer Research and Treatment 102: 365-374.
Sotheran, W., Domjan, J., Jeffrey, M., Wise,
M.H. & Perry, P.M. 2005. Phyllodes tumours of the
breast- a retrospective study from 1982-2000 of 50 cases in Portsmouth. Annals
of Royal College of Surgeons of England 87: 339-344.
Speirs, V., Skliris, G.P., Burdall, S.E. &
Carder, P.J. 2002. Distinct expression
patterns of ERα and ERβ in normal human mammary gland. Journal of
Clinical Pathology 55: 371-374.
Tan, P.H., Jayabaskar, T., Chuah, K.L., Lee,
H.Y., Tan, Y., Hilmy, M., Hung, H., Selvarajan, S. & Bay, B.H. 2005. Phyllodes tumors of the breast. The role of pathologic parameters. American Journal of
Clinical Pathology 123: 529-540.
Tan, P.H., Tse, G., Lee, A., Simpson, J.F. &
Hanby, A.M. 2012a. Fibroepithelial tumors. Dlm. World Health Organization Classification of Tumours. Pathology WHO Classification of Tumours of the Breast disunting oleh
Lakhani, S.R., Ellis, I.O., Schnitt, S.J., Tan, P.H. & van de Vijver, M.J.
Lyon: IARC Press.
Tan, P.H., Thike, A.A., Tan, W.J., Myint Thu, M.M., Busmanis, I.,
Li, H., Chay, W.Y., Tan, M.H. & The Phyllodes Tumour Network Singapore.
2012b. Predicting clinical behaviour of breast phyllodes tumours: A nomogram
based on histological criteria and surgical margins. Journal of Clinical
Pathology 65(1): 69-76.
Tsai, W.C., Jin, J.S., Yu, J.C. & Sheu, L.F. 2006. CD10,
Actin, and Vimentin expression in breast phyllodes tumors correlates with tumor
grade of WHO grading. International Journal of
Surgical Pathology 14: 127-131.
Tse, M.K., Lee, C.S., Kung, Y.L., Scolyer, F.,
Law, R.A., Bonita, K.B., Lau, T.S. & Putti, T.C. 2002. Hormonal receptors expression in epithelial cells of mammary
phyllodes tumors correlates with pathologic grade of the tumor. A multicenter study of 143 cases. American Journal of
Clinical Pathology 118: 522-526.
Tse, M.K., Chai, B., Lau, K.M., Scolyer, R., Lee, C.S., Karim,
R.Z., Putti, T.C., Law, B.K., Lui, P.C. & Tan, P.H. 2007. Endothelin-1
expression correlates with a typical histological features in mammary phyllodes tumours. Journal of Clinical Pathology 60(9):
1051-1056.
Wittliff, J.L., Pasic, R. & Bland, K.I. 1998. Steroid and
peptide hormone receptors: Methods, quality control and clinical use. Dlm The
Breast: Comprehensive Management of Benign and Malignant Diseases. Edisi
pertama, disunting oleh Bland, K.I. & Copeland, E.M. Philadephia: Elsevier
Saunder Publisher.
Yonemori, K., Hasegawa, T., Shimizu, C.,
Shibata, T., Matsumoto, K., Kauno, T., Ando, M., Katsumata, N. & Fujiwara,
Y. 2006. Correlation of p53 and MIB-1
expression with both the systemic recurrence and survival in cases of phyllodes
tumors of the breast. Pathology, Research & Practice 202:
705-712.
Zainal, A.O. & Nor-Saleha, I.T. 2011. Malaysia
Cancer Statistics- Data and Figure. National
Cancer Registry Report. Kuala Lumpur: Ministry of Health Malaysia.
*Pengarang
untuk surat-menyurat; email: saishah@ppukm.ukm.edu.my
|